(Adds confirmation, health agency comment, includes AstraZeneca
shot)
COPENHAGEN, June 25 (Reuters) - Danish health authorities
said on Friday that COVID-19 vaccines from AstraZeneca
and Johnson & Johnson would remain excluded from
Denmark's vaccine roll-out following a review of new safety
data.
"The balance between possible benefit and possible harmful
effects is still not favourable, even when we include
assumptions in our analyses that benefit the vaccine," the
Danish Health Authority said in a statement.
Denmark was the first country to suspend and altogether
ditch Johnson & Johnson's and AstraZeneca's
COVID-19 vaccines over safety concerns due to their potential
link to a rare but serious form of blood clot.
(Reporting by Nikolaj Skydsgaard;
Editing by Alison Williams and Edmund Blair)